Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 2,476 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Healthy
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer
Interventions: dMD-002, Control; Device · Other
Lead sponsor: Mochida Medical USA, Inc.; Industry
Eligibility: 40 Years to 74 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Dystonic Disorders, Healthy
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer, Prostate Adenocarcinoma
Interventions: Radical Prostatectomy, TULSA Procedure; Device
Lead sponsor: Profound Medical Inc.; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2036
U.S. locations: 19
States / cities: Chandler, Arizona • Mesa, Arizona • Scottsdale, Arizona + 14 more

Conditions: Healthy Subjects, Mental Health Issue
Interventions: Music composition / edition, Photography composition / edition; Behavioral
Lead sponsor: New York University; Other
Eligibility: 13 Years to 16 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Brooklyn, New York • New York, New York

Conditions: Osteoarthritis
Interventions: Bone Marrow Derived MSCs, Adipose-derived MSCs, Umbilical Cord Tissue (UCT) MSCs, Corticosteroid injection; Biological · Drug
Lead sponsor: Emory University; Other
Eligibility: 40 Years to 70 Years
Enrollment: 475 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 5
States / cities: Gulf Breeze, Florida • Atlanta, Georgia • Durham, North Carolina + 2 more

Conditions: Stress Urinary Incontinence
Interventions: lidocaine with epinephrine, Normal saline with epinephrine; Drug
Lead sponsor: West Penn Allegheny Health System; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 4
States / cities: Bethel Park, Pennsylvania • Jefferson Hills, Pennsylvania • Pittsburgh, Pennsylvania + 1 more

Conditions: Proteinuria, Idiopathic Membranous Nephropathy
Interventions: Repository Corticotropin Injection, Placebo; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 14
States / cities: Sacramento, California • Stanford, California • Jacksonville, Florida + 11 more

Conditions: Diabetes, Hyperglycemia, Surgical Site Infection
Interventions: Tight Glycemic, Conventional Glycemic, Standard Glycemic; Drug
Lead sponsor: James A. Haley Veterans Administration Hospital; Federal
Eligibility: 21 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Leiomyoma
Interventions: Mifepristone, Inert Capsule; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Physical Activity
Interventions: Deep south Interactive voice response system supported Active Lifestyle (DIAL); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 245 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Neonatal Abstinence Syndrome
Interventions: Clonidine HCL, saline; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 5 Days to 90 Days
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Overweight, Obesity, Healthy Adults
Interventions: Acetaminophen, Placebo, Weight stigma vignette, Control vignette; Drug · Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cancer
Interventions: Brief Motivational Intervention; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: Not listed
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Hepatic Impairment
Interventions: Telotristat Ethyl; Drug
Lead sponsor: Lexicon Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 3
States / cities: Miami, Florida • Orlando, Florida • San Antonio, Texas

Conditions: Obesity, Labor, Induced, Oxytocin
Interventions: Oxytocin; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older · Female only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Healthy
Interventions: Yohimbine; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy Volunteers
Interventions: Shock Device, Auditory Startle Device; Device
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 1,418 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mucosal Erosion, Gingival Recession
Interventions: Visual Analog scale (VAS) questionnaire, Vacuum-formed retainer (VFR) technique, 3-D printed acrylic resin stent (3DS) technique, Flowable resin composite stent (FRC) technique, Photographs of the patient's palate, Measuring graft dimensions, Chairside Polymer Stent; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Venous Stasis Ulcers
Interventions: Revera Wound Care, Normal Saline; Device
Lead sponsor: Revalesio Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Benign Prostatic Hyperplasia
Interventions: Tranexamic Acid (IV), Placebo; Drug
Lead sponsor: Kaiser Permanente; Other
Eligibility: 45 Years and older · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depressive Disorder, Major, Bipolar Depression, Suicidal Ideation
Interventions: Triple Chronotherapy, Treatment as Usual; Behavioral
Lead sponsor: Billings Clinic; Other
Eligibility: 12 Years to 17 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Billings, Montana

Conditions: BK Virus (Nephropathy)
Interventions: Cidofovir, Placebo; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 12
States / cities: Birmingham, Alabama • San Francisco, California • Aurora, Colorado + 7 more

Conditions: Sickle Cell Disease, Vaso-occlusive Pain Episode
Interventions: L-arginine, L-arginine Loading Dose, Placebo; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 3 Years to 21 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 3
States / cities: Atlanta, Georgia

Search by objective public record fields.

Biological Specimen Collection for Laboratory Methods Development and Training Purposes

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

Surround Inhibition in Patients With Dystonia

A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer

A Music and Visual Arts Digital Intervention in Teenagers to Promote Healthy Engagement With Social Media.

Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)

The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

The Effect of Tight Glycemic Control on Surgical Site Infection Rates in Patients Undergoing Open Heart Surgery

Trial of Mifepristone for Fibroids

Testing Scalable, IVR-supported Cancer Prevention Interventions in the Rural Alabama Black Belt

Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants

Pain and Acetaminophen in Women Study

Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors

Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment

Oxytocin Dosage to Decrease Induction Duration

Brain Receptors in Sympathetic Nervous System Regulation

Effects of Arousal and Stress in Anxiety

Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques

Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers

Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation

Triple Chronotherapy in Adolescents

Cidofovir in Renal Transplant Recipients With BKVN

Arginine Therapy for Sickle Cell Disease Pain